Visual Impairment Following Periocular Triamcinolone Acetonide Injection into the Lacrimal Gland: A Case Report and Literature Review.
Vision loss after triamcinolone injection into the lacrimal gland can fully recover.
Visual Impairment Following Periocular Triamcinolone Acetonide Injection into the Lacrimal Gland: A Case Report and Literature Review.
Idiopathic dacryoadenitis is a diagnosis of exclusion and may present with unilateral or bilateral eyelid swelling, erythema, pain, and characteristic S-shaped ptosis of the upper eyelid.
We searched the PubMed database for relevant reports and herein describe the case of a 36-year-old woman with idiopathic dacryoadenitis who developed acute vision loss during lacrimal gland triamcinolone acetonide injection.
Glucocorticoids remain the mainstay of treatment when symptoms are functionally limiting or clinically significant.
Although local triamcinolone acetonide (triamcinolone acetonide) injection provides targeted anti-inflammatory effects with fewer systemic adverse effects, it carries a rare but potentially catastrophic risk of iatrogenic vascular embolization and acute vision loss.
Here, we report a case of complete visual recovery after such an injection.
Intraglandular triamcinolone administration for dacryoadenitis can cause severe vision loss.
Although prompt multimodal management may restore vision, prognosis depends on treatment timing, embolic site, therapeutic choices, and individual patient factors.
Reinforcing preventive precautions is essential to minimize this rare but potentially catastrophic risk. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article.